1.	Long Term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: INS-06-007, INSYS-INS-06-007, NCT00538863
2.	Phase III Randomized Study of Fentanyl Sublingual Spray for Breakthrough Cancer Pain in Patients Who are Opioid Tolerant Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: INSYS-INS-05-001, INS-05-001, NCT00538850, NCT00538850
3.	Phase III Study of Fentanyl Sublingual Spray in Opioid-Tolerant Cancer Patients With or Without Oral Mucositis Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: INSYS-INS-09-011, INS-09-011, NCT00956254